MAGNETOM Combi Suite
Combining MRI intelligence and therapeutic expertise.
Combining MRI intelligence and therapeutic expertise.
MAGNETOM Combi Suite* brings the MRI intelligence of MAGNETOM® Aera 1.5T and MAGNETOM Skyra 3T to your therapeutic procedures in neurosurgery as well as neuro- and cardiovascular interventions, and even radiation therapy treatment planning.
Your benefits:
With the innovative MAGNETOM Combi Suite, Siemens, the market leader in multimodality suites, has created a dedicated solution to integrate MRI into therapy – designed with your specific requirements in mind.
MAGNETOM Combi Suite seamlessly integrates MRI into your clinical processes – with a smooth patient transfer to and from the MRI system and support in treatment planning. Intelligent MR image information supports treatment decisions – before, during, and after the procedure.
Your clinical procedures combined with Siemens’ MRI systems with top-of-the-line image quality enabled by Tim® 4G + Dot®: excellent soft tissue contrast and differentiation, plus MRI-exclusive imaging techniques that provide valuable morphological and functional information.
* The product is still under development and not commercially available yet. Its future availability cannot be ensured.
Siemens’ innovative solution MAGNETOM Combi Suite Neurosurgery allows for MRI in the Neuro-OR setting with a smooth patient transfer to and from the MRI system. Intraoperative MRI imaging provides valuable information that might change your surgical strategy.
MAGNETOM Combi Suite can be configured to your needs: You can integrate MAGNETOM Aera 1.5T or MAGNETOM 3T Skyra the OR table of choice: The dedicated solution is compatible with both MAQUET and TRUMPF surgical tables.
The dedicated Combi Dockable Table transfers your patient to and from the MRI system – with one single transfer, robust, smooth, and flexible. Designed with your neurosurgical workflow in mind, the table offers free space below the shell to attach your head clamp, allowing better ergonomics for you and the patient.
Discover superior MRI visualization of brain morphology and function and benefit from intraoperative MRI applications.
* The product is still under development and not commercially available yet. Its future availability cannot be ensured.
This suite brings MRI to your interventional planning and control in neuro- and cardiovascular procedures. Transferring the patient from the angio suite to the MRI system supports you in interventions such as atrial fibrillation with MR imaging excellence.
With MAGNETOM Artis Combi Suite, you can utilize the imaging power of MAGNETOM Aera 1.5T or MAGNETOM Skyra 3T and the Artis zee family. Artis zee systems are specifically designed to meet the escalating demands of interventional imaging today and in the future.
The dedicated Combi Dockable Table transfers the patient directly from Artis zee to the MRI system and vice versa - either with a table transfer or rail transfer. Robust, smooth, and flexible - and without the need for patient repositioning.
See detailed anatomic and physiologic information, soft tissue and functional contrasts - with MRI.
* The product is still under development and not commercially available yet. Its future availability cannot be ensured.
The dedicated solution MAGNETOM Combi Suite Radiation Therapy lets you integrate magnetic resonance imaging into your radiation therapy treatment planning process. MRI’s excellent soft-tissue differentiation supports target structure delineation and identification of structures at risk.
With MAGNETOM Combi Suite Radiation Therapy, you can integrate MAGNETOM Aera 1.5T or MAGNETOM Skyra 3T into your RT treatment planning workflow: Dedicated indexed table tops help enable reproducible RT-like patient positioning, special coil holders support mounting Tim 4G coils. And, the Tim Dockable Table offers staff flexibility in patient preparation and time slot scheduling.
Benefit from MRI’s excellent soft-tissue differentiation and advanced applications like MR spectroscopy and syngo REVEAL for additional pathology characterization.
* The product is still under development and not commercially available yet. Its future availability cannot be ensured.